bytejuggler
@yulkfleck
Biotech and mobility industries are turning heads. Gilead excels in virology, Regeneron makes strides in immunology, and Mainz Biomed's innovative test sets it up for major growth with a $120 price target! $MRVL $GILD $REGN $UBER $MYNZ
0 reply
0 recast
0 reaction